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Background: Induced pluripotent stem (iPS) cells can differentiate into any cell type, which makes them an
attractive resource in fields such as regenerative medicine, drug screening, or in vitro toxicology. The most
important prerequisite for these industrial applications is stable supply and uniform quality of iPS cells. Variation in
quality largely results from differences in handling skills between operators in laboratories. To minimize these
differences, establishment of an automated iPS cell culture system is necessary.
Results: We developed a standardized mouse iPS cell maintenance culture, using an automated cell culture system
housed in a CO2 incubator commonly used in many laboratories. The iPS cells propagated in a chamber uniquely
designed for automated culture and showed specific colony morphology, as for manual culture. A cell detachment
device in the system passaged iPS cells automatically by dispersing colonies to single cells. In addition, iPS cells
were passaged without any change in colony morphology or expression of undifferentiated stem cell markers
during the 4 weeks of automated culture.
Conclusions: Our results show that use of this compact, automated cell culture system facilitates stable iPS cell
culture without obvious effects on iPS cell pluripotency or colony-forming ability. The feasibility of iPS cell culture
automation may greatly facilitate the use of this versatile cell source for a variety of biomedical applications.
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PluripotencyBackground
Since the development of induced pluripotent stem (iPS)
cells, their use has been anticipated in various areas, in-
cluding regenerative medicine and drug discovery [1,2].
The advantages of iPS cells include their multipotency,
and they can be established from individuals, allowing
the creation of pluripotent stem cells from any donor
with any genetic background [3-5]. Hepatocytes derived
from iPS cells are useful in evaluating drug sensitivity
and toxicity and also in understanding highly variable
pathological conditions [6,7]. Obtaining mature cells like
hepatocytes for drug development is impeded by short
supply, high cost, and variable quality [8]. To solve these* Correspondence: rtanigu@med.yokohama-cu.ac.jp
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reproduction in any medium, provided the orproblems, directed differentiation of iPS cells into som-
atic lineages in vitro has been attempted extensively
[9-11]. Once the creation of mature, functional hepato-
cytes from iPS cells is successful, the development of
stable supply system of iPS cells will be necessary for
their translation to these applications.
In this regard, it is important to establish an auto-
mated cell culture system (ACCS), which facilitates
stable and standardized iPS cell culture and enables
researchers to handle sufficient quantities of iPS cells.
To date, such ACCS are difficult to handle in a space-
limited research laboratory. Therefore, iPS cell culture is
still dependent on manual techniques. Cell culture con-
ditions, such as duration of treatment with cell detach-
ment solution, fluid flow, and seeding cell density, are
difficult to control. To preserve the pluripotency of stem
cells, culture requires precise control by highly skilled
operators because complicating factors cause difficulty
in scaling-up the stem cell culture system [12,13]. Totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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necessary to standardize cell culture operations.
In this study, we describe an ACCS that enables auto-
mated iPS cell culture in a commonly used cell culture
incubator. We standardized the maintenance of iPS cell
culture and demonstrated long-term subculture of iPS
cells using a device that automates both the positioning
of seeding cells on feeder cells and their passaging.
Results and discussion
Automated induced pluripotent stem cell culture system
In the development of a mass production system for iPS
cells, it is desirable that a uniform quality of cultured
cells is maintained for a long-term. Stem cell culture is
dependent on manual processes performed by skilled
technicians at all stages [12]. Therefore, quality and
safety is limited by the technique and skill of the workerFigure 1 The Automated Cell Culture System is Composed of a Cell D
culture system, the components of which fitted inside a commonly used C
components connected by closed flow path.[14]. In particular, iPS cells are very difficult to handle,
as they have a tendency to change state easily upon each
passage or operation because of which it is difficult to
obtain consistent results with iPS cells. Therefore, it is
necessary to automate the operations for a series of cul-
tures. We developed a culture system capable of provid-
ing a stable supply of normal mouse iPS cells using
ACCS (Figure 1A). This device automates stem cell cul-
ture, allows optimization, and enhances safety. ACSS
automatically performed injection/aspiration of cell and
liquid by the rotation of peristaltic pumps and the
switching of the flow paths. Detachment system could
dissociate the adherent cells by giving vibration to the
culture chamber. Parameters such as fluid flow rate, vol-
ume, dilution ratio, enzymatic reaction time, and detach-
ment time, were optimized and can be controlled
through external PC.etachment System and Stack System. (A) Photograph of automated
O2 incubator. (B) Schematic illustration of the whole system with
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industrial use (Figure 1B). It requires no centrifugation
step for cell collections. As described above, iPS cells
need careful maneuver; therefore, we suggest the need
for an automated system for mass production in a bio-
medical or pharmaceutical plant. This small system is
suitable for commercial adoption because it can be
incorporated flexibly into a plant.
Cell culture in a disposable cell chamber (DCC)
Mouse iPS cell cultivation was carried out in chamber
uniquely designed for ACCS (Figure 2A). A disposable
cell chamber (DCC) was a closed chamber with a total
volume of 4.65 ml. We dispensed 1 × 105 iPS cells into
each DCC. Oxygen demand is a critical factor in stem
cell culture; therefore, tight control of the culture envir-
onment was necessary [15]. In DCC, air exchange was
performed through an aerated filter on top face. Dis-
solved oxygen levels in the medium in the chamber were
maintained between 50–80% of the saturation of air after
2 days of cell culture (Figure 2B), comparable to conven-
tional cell culture using a dish (data not shown).
Passaging of induced pluripotent stem cells in the
automated culture device
In iPS cell culture, cell dissociation is the most import-
ant step. Usually, stem cell dispersion during manual
passage is carried out using enzymatic and mechanical
methods that are least disruptive to pluripotency [16].
iPS cells should remain as single cells from suspension
to passage because a majority of the cells would not per-
sist in a pluripotent state if they are not dissociated into
single cells [17]. We optimized the method using both
enzyme treatment and mechanical dissociation to
achieve single cell automatic passage (Figure 3A). To
monitor iPS cell pluripotency during cell culture, we uti-
lized the fact that iPS cells are derived from transgenic
mice line in which green fluorescent protein (GFP) is
under the control of the Nanog promoter [18]. TheFigure 2 Disposable Cell Chamber Exchanged Oxygen through Air Fil
used in this study. (B) Dissolved oxygen concentration in DCC. Concentrati
iPS cells.Nanog-GFP transgenic mice express GFP in a pattern
that is identical to that of Nanog, a known pluripotent
marker.
Detached iPS cells, suspended with shaking incubation
in the cell detachment unit after a 30 min-protease
treatment, dissociated into single cells. After dissoci-
ation, cells were collected and plated in new DCCs
through a tube with inserted needle. Morphological ana-
lysis showed that iPS cells were successfully dissociated
into single cells after the passaging process (Figure 3A).
No difference was observed in morphology and size of
mouse iPS cell colonies between the DCC culture and
manual culture in a dish (Figure 3B,C). Moreover, the
iPS cell colonies in DCC showed intense Nanog-GFP
fluorescence after automated culture (Figure 3B).
Morphological analysis of induced pluripotent stem cells
over multiple passages in the automated culture device
The growth characteristics of iPS cells propagated in
ACCS were comparable to those propagated manually.
Repeated medium changes and passaging every 2 days by
the automated method so that did not compromise the
integrity of the iPS cell culture. No microbial contamin-
ation was observed, even after 4 weeks. Throughout the
long-term culture, there were no morphological changes
in mouse iPS cells cultured by the automated culture sys-
tem (Figure 4A). No significant change was observed in
Nanog-GFP positive areas and frequency during culture,
suggesting that the undifferentiated state, growth rate
and viability of iPS cells was maintained for over 17
passages, i.e., about 4 weeks of culture (Figure 4B, C).
Expression of pluripotency-associated markers over
multiple passages in automated culture device
Next we examined the expression of pluripotent markers
in iPS cells in automated culture over a period of 4 weeks
using immunohistochemistry, alkaline phosphatase assay,
and quantitative Reverse Transcription Polymerase Chain
Reaction (qPCR). Stage-specific embryonic antigenter, Leading to the Proliferation of Cells. (A) Photograph of DCC
on of dissolved oxygen was measured each day for 3 days. On Day 0,
Figure 3 Mouse Induced Pluripotent Stem Cells Passaging by Automated Cell Culture System. onfluent cells were were plated on to
mouse embryonic fibroblast feeder cells. Dissolved oxygen concentration was measured aseptically using an optical sensor at RT. The data is
shown as mean ± standard deviation; number of chambers: 3.
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carcinoma cells, is widely used for the identification
of stem cells [19,20], whereas SSEA-1 is expressed in
undifferentiated mouse iPS cells [21,22]. We showed
that during 4 weeks of automated culture, the expres-
sion of SSEA-1 and SSEA-3 was maintained in mouse
iPS cell cultures (Figure 5A). Undifferentiated iPS cells
are known to exhibit tissue nonspecific alkaline phos-
phatase activity [22]. Using alkaline phosphatase assay
we observed that the alkaline phosphatase activity was
maintained for over 4 weeks (Figure 5B). Furthermore,
we examined the expression of pluripotency markers by
quantitative qPCR. Nanog, Oct3/4, and Sox2 mRNAs
have all been identified as undifferentiated cell marker
genes in iPS and embryonic stem (ES) cells [23],
while CD13 is expressed in fibroblasts [24]. After 4
weeks of automated culture, expression of these mar-
ker mRNAs was equivalent to the pre-culture levels
(Figure 5C). These results indicate that the automated
cell culture device did not alter gene expression levels
for pluripotency-associated transcription factors, indi-
cating that maintenance culture of mouse iPS cells is
possible for long-term.
To evaluate whether the iPS cells cultured with ACCS
have maintained differentiation property, embryoid bod-
ies (EB) were generated after period of culture. EB were
plated on the dish and cultured for additional 2days.
Expression of the differentiation markers was examinedby qPCR. Gene expression of ectoderm, mesoderm, and
endoderm markers were increased respectively. This
result indicated that iPS cells cultured with ACCS have
maintained the multi-lineage differentiation potential.
Conclusion
In this study, we established an automated culture that
enabled multiple passages of mouse iPS cells without
affecting their pluripotency. We believe that ACCS
established in this study has met the requirement of
standardized iPS cell quality, which was verified by
morphology, proliferation, and expression of markers for
undifferentiated cells. In a recent study, it was demon-
strated that mouse iPS cells are closer to the ground
state than human pluripotent stem cells and human iPS
cells can be put back in the ground state under particu-
lar culture conditions [25]. Unlike mouse iPS cells,
human iPS cells must passage as cell aggregates, and dis-
sociation into single cells leads to differentiation. It will
be useful to propagate human iPS cells with ACCS by
optimization of parameters, such as flow rate and dis-
perse reaction time. It will also be possible that human
iPS cells cultured with ACCS by simply applying mouse
iPS cell condition establish in this study under the pres-
ence of ROCK inhibitors which enhance human iPS cell
survival as a single cell [26,27]. This automated culture
system, which produced a steady supply of pluripotent
stem cells of constant quality, will serve as a base
Figure 4 Long-Term Induced Pluripotent Stem Cell Culture using Automated Cell Culture System. (A) Morphology and corresponding
fluorescence of GFP, under the control of the Nanog promoter, of each mouse iPS colony passaged automatically for long-term culture. The
mouse iPS cells were cultured for 4 weeks and passaged 17 times. Scale: 100 μm. (B) Quantification of iPS cell proliferation based on colony size
by Nanog-GFP expression compared with the first passage iPS cells. (C) Quantification of iPS cell viability based on colony forming frequency by
Nanog-GFP expression compared with the first passage iPS cells.
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bulk. For the application of these stem cells in advanced
medicine, the next challenge will be to develop a method
to efficiently induce differentiation of pluripotent stem
cells with an automated culture system.
Methods
Automatic cell culture
ACCS consisted of three main components: a computer
including software, control box, and cell culture system
(Figure 1). The cell culture system is operated with the
computer through the control box. The cell culture sys-
tem is a cell-passage machine in an incubator compris-
ing a cell detachment device, a cell chamber stack tower,
and a solution exchange system. Cells that were pre-
cultured in DCC were placed in the stack tower and
detached mechanically in a protease solution (TrypLE
Express, Life technologies Co.) after a phosphate-
buffered saline wash. After detachment, the cells weredissociated by passing through a needle inserted into the
DCC cell suspension diluted with culture medium, then
dispensed into new DCCs in the stack tower. All steps
after pre-culture were processed automatically by ACCS.
Oxygen concentration in DCCs was measured using an
optical oxygen sensor (Microx TX3, PreSens Precision
Sensing GmbH).
Culture of mouse induced pluripotent stem cells
The Nanog-GFP mouse iPS cells line iPS-MEF-Ng-20D-
17 established as described previously [18] were cultured
for 4 weeks using the automated culture device. Chambers
coated with 0.1% gelatin were seeded automatically with
mitomycin-inactivated mouse embryonic fibroblast (MEF)
isolated from non-visceral tissues of day E13.5 mouse
embryos 6 h prior to every iPS cell passaging from another
chamber loaded MEF suspension. All animal experiments
were approved by the Ethics Committee of Yokohama
City University and were conducted according to the
Figure 5 Undifferentiated State of Induced Pluripotent Stem Cells after Long-Term Culture using Automated Cell Culture Device. (A)
Alkaline phosphatase activity of iPS cells at 0 and 17 passages. Scale: 100 μm. (B) Immunostaining of the pluripotency markers SSEA-1 and SSEA-3
in iPS cells at 0 and 17 passages. Scale: 100 μm. (C) Quantitative PCR analysis of the gene expression of the stem cell markers Oct3/4, Sox2, and
Nanog, and the fibroblast marker CD13 compared with the MEFs. (D) Quantitative PCR analysis of the gene expression in EBs derived from
automatically cultured iPS cells. The expressions of pluripotency markers; Zfp42, Nanog, endoderm markers; Ttr, Afp, mesoderm markers; Myh6,
Brachyury, and ectoderm markers; Gfap, Nes, were compared with the iPS cells. *Statistically significant (p <0.05).
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10,000 cells/cm2. The culture medium comprised of Dul-
becco’s modified Eagle’s medium (GIBCOW; Life Tech-
nologies) containing 15% Knockout™ Serum Replacement
(Life technologies), GlutaMAX™ (Life technologies), non-
essential amino acids, and β-mercaptoethanol. Repeated
passaging was performed every 2 days by automated
method. In the passage process, mouse iPS cells were dis-
sociated with TrypLE™ Express (Life technologies) as mix-
ture with MEFs and dispersed into single cells and dilutedby fresh medium before seeding. The dissolved oxygen
concentration in DCC was kept for 2 days cultivation, so
that iPS cell growth would not be affected. For automated
culture, centrifugation steps were performed outside the
automated device. After every passage, cells were sub-
jected to morphological evaluation. For quantification of
iPS cell growth, fluorescent images were processed using
IN Cell Developer Toolbox software (GE Healthcare, Fair-
field, CT, USA), and the sizes of iPS cell colony were mea-
sured as GFP positive area.
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Adherent cultures were fixed with 4% paraformaldehyde
for 10 min at room temperature (RT) and rinsed with
phosphate-buffered saline. For SSEA-1 and SSEA-3
staining, cells were pre-incubated with 10% goat serum
(Sigma-Aldrich, Missouri, USA) for 1 h at RT. Cells were
incubated overnight at 4°C with the appropriate concen-
tration of primary antibodies in 1% goat serum solution
(mouse-anti-SSEA-1 1:200, Santa Cruz Biotechnology;
rat-anti-SSEA-3 1:200, Millipore). Antigens were visua-
lized using the appropriate fluorophore-conjugated sec-
ondary antibodies (Alexa FluorW 555 goat anti-mouse
IgG (H+L), 1:500, Life Technologies; Alexa FluorW 488
goat anti-rat IgG, 1:500, Life Technologies). Nuclear
staining was performed with 40,6-diamidino-2-phenylin-
dole (1:2,000 in Apathy’s mounting medium, Sigma-
Aldrich) for 5 min. Fluorescence images were captured
using a fluorescence microscope (IX-71, Olympus,
Tokyo, Japan). For evaluation of cell dissociation, cells
were fixed with 4% PFA for 10 min at RT and then
washed with phosphate-buffered saline. Phase contrast
images and fluorescence images of GFP-expressing cells
were captured using a wide-field fluorescence micro-
scope (DMI6000B, Leica Microsystems). We checked
that Nanog-GFP fluorescence in iPS cells was dimin-
ished during the fixation and immunocytochemical
staining operations and was negligible compared to the
positive signal.Alkaline phosphatase assay
For alkaline phosphatase staining, cells were fixed with
citrate solution with added acetone and formaldehyde
for 30 s at RT, rinsed with deionized water, and treated















Gapdh AGCTTGTCATCAACGGGAAGEB formation and differentiation
For EB formation, hanging drop method was performed.
Hanging drops (one droplet [30μl] contains 1000 iPS
cells cultured with ACCS) were placed on the lid of a
100 mm dish filled with phosphate-buffered saline (PBS)
and cultured for 7days. EBs were transferred to attach-
ment cultures for further differentiation.
Quantitative analysis using real-time PCR (qPCR)
After 4 weeks of automated cell culture, total RNA
was isolated from mouse iPS cells using TRIzolW Re-
agent (Life Technologies), and reverse transcription
was carried out using a High Capacity cDNA Archive
Kit (Life Technologies). The PCR mix in each well
included 10 μl of EagleTaq Master Mix with ROX
(Roche Applied Science), 0.2 μl each of the forward
and reverse primers (10 ng/μl), and 5 μl of single-
strand cDNA, giving a final reaction volume of 20 μl.
qPCR was performed with LightCyclerW 480 system
(Roche Applied Science, Germany) using the Universal
ProbeLibrary (UPL) probes (Roche Applied Science).
The relative quantification of gene expression was car-
ried out according to the delta-delta Cp method.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was chosen as the reference gene. Mouse-specific pri-
mer sequences (forward and reverse) and Universal
ProbeLibrary probes are listed in Table 1. The following
PCR conditions were used: 50°C for 2 min, 95°C for
10 min, 95°C for 15 s, and 60°C for 1 min, for a total
of 55 cycles.
Statistics
Data were presented as the mean ± SD. Statistical differ-
ences were analyzed using the Mann–Whitney U test. P
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